| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/15/2006 | CN1732756A Method for inducing, breeding and transplanting triperygium wilfordii cluster buds |
| 02/15/2006 | CN1242064C Transgene plant breeding method using Rice flavamonocell hrf 1 gene |
| 02/15/2006 | CN1242058C Method for preparing tissue engineered corneal epithelium implantation sheet from epidermis stem cell, and its application |
| 02/15/2006 | CN1242057C Simple process for cultivating organization cell of antler |
| 02/15/2006 | CN1241944C Antibody againts 'alpha'-chain of human interleukin 5 receptor |
| 02/15/2006 | CN1241940C Novel collagen-like protein CLAC, Precursor thereof and genes encoding the same |
| 02/15/2006 | CN1241638C IFNAR2/I FN complex |
| 02/14/2006 | US6998519 Cotton cultivar 01Z34 |
| 02/14/2006 | US6998518 Soybean variety 91M50 |
| 02/14/2006 | US6998514 Murine expression of a human IgA lambda locus |
| 02/14/2006 | US6998513 Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use |
| 02/14/2006 | US6998476 Nucleic acids encoding antagonists of interleukin-15 |
| 02/14/2006 | US6998475 Variants of traf2 which act as an inhibitor of tnf-alpha (tnfα) signaling pathway |
| 02/14/2006 | US6998474 used for prevention and/or treatment of pathologies, dysfunctions, disorders or conditions affecting the nervous system |
| 02/14/2006 | US6998473 isolated polynucleotide molecules which encode the isoforms ; methods of screening compounds for vitamin D receptor (VDR) agonists and/or antagonists |
| 02/14/2006 | US6998472 Obesity gene |
| 02/14/2006 | US6998471 Plant extract; hybrid nucleic acids; genetic engineering; polymerase chain reactions cycles |
| 02/14/2006 | US6998468 Anti-C2/C2a inhibitors of complement activation |
| 02/14/2006 | US6998467 diagnosing for and detection of carriers of the gene, Alzheimer's Disease diagnosis, gene therapy using recombinant technologies and therapy using the information derived from the DNA, protein, and the metabolic function of the protein |
| 02/14/2006 | US6998383 Inhibitors of receptor activator of NF-κB and uses thereof |
| 02/14/2006 | US6998267 transformed plant cell is obtained by introducing to a plant cell a gene encoding a glycosyltransferase enzyme and a gene encoding an exogenous glycoprotein, cultivating the obtained transformed plant cell |
| 02/14/2006 | US6998266 Active retinoic acid-free culture medium for avian totipotent embryonic stem cells |
| 02/14/2006 | US6998265 Method and apparatus to grow and mechanically condition cell cultures |
| 02/14/2006 | US6998264 Replication of biological tissue |
| 02/14/2006 | US6998260 DNA expression construct comprising, in 5' to 3' order: a promoter operationally linked to a secretion signal sequence, the secretion signal sequence operationally-linked to a DNA sequence encoding a proteolytic tryptase having active site mutation |
| 02/14/2006 | US6998257 Recombinant minimal catalytic vanadium haloperoxidases and their uses |
| 02/14/2006 | US6998253 polypeptide of interest is cleared from kidney and does not contain a Fc region of an IgG, which variant comprises a salvage receptor binding epitope of an Fc region of an IgG, and which variant has a longer in vivo half-life than the polypeptide |
| 02/14/2006 | US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist |
| 02/14/2006 | US6998239 contacting an isolated or recombinant CCX CKR polypeptide or, a fragment or variant, and the chemokine in the presence of a test compound, comparing the level of binding of the chemokine and the polypeptide |
| 02/14/2006 | US6998229 Used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample |
| 02/14/2006 | US6998122 which retain wild-type biological activity and extend half-lives in human blood; resistant to serpin activation; for treatment of vascular occlusive disorders, hypercoagulable states, and thrombotic disorders |
| 02/14/2006 | US6998118 Transducing neuron with gene; Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis |
| 02/14/2006 | CA2384170C Cgmp-visualizing probe and method of detecting and quantifying cgmp by using the same |
| 02/14/2006 | CA2383391C Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 02/14/2006 | CA2303712C Oilseed brassica containing an improved fertility restorer gene for ogura cytoplasmic male sterility |
| 02/14/2006 | CA2288793C Poly(vinyl alcohol) cryogel |
| 02/10/2006 | CA2504451A1 Dendritic cell vaccines for treating cancer made from embryonic stem cells |
| 02/09/2006 | WO2006015368A2 Molecules with effects on cellular development and function |
| 02/09/2006 | WO2006015365A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof |
| 02/09/2006 | WO2006015304A2 Amorphous cell delivery vehicle treated with physical/physicochemical stimuli |
| 02/09/2006 | WO2006015214A2 Umbilical cord stem cell composition & method of treating neurological diseases |
| 02/09/2006 | WO2006015209A2 Differentiation of stem cells |
| 02/09/2006 | WO2006014903A2 Compositions and methods of use for adam12 antagonists in treating disease |
| 02/09/2006 | WO2006014642A1 Method of producing autologous embryonic stem cells |
| 02/09/2006 | WO2006014578A2 Method and composition for longevity assurance |
| 02/09/2006 | WO2006014551A2 In vivo methods for effecting tissue specific differentiation of embryonic stem cells |
| 02/09/2006 | WO2006014505A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 02/09/2006 | WO2006014159A2 Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| 02/09/2006 | WO2006014157A1 Methods of using regenerative cells to promote wound healing |
| 02/09/2006 | WO2006013824A1 Biosample freezing apparatus and method of freezing |
| 02/09/2006 | WO2006013807A1 Arabinogalactan protein having activity of improving tolerance to heat or moisture stress |
| 02/09/2006 | WO2006013472A2 Novel anti-igf-ir antibodies and uses thereof |
| 02/09/2006 | WO2006013334A1 Hai-1 and hai-2 in cancer therapy |
| 02/09/2006 | WO2006013159A2 Method for isolating and culturing stem cells |
| 02/09/2006 | WO2006012837A2 Graft structure comprising terminally differentiated tissue cells for the reconstruction of an organ |
| 02/09/2006 | WO2005123911A3 Proteases |
| 02/09/2006 | WO2005070090A3 Regulatory t cells suppress autoimmunity |
| 02/09/2006 | WO2004113517A3 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 02/09/2006 | WO2004056983A3 Metalloprotease proteins |
| 02/09/2006 | WO2003068923A3 Signal for packaging of influenza virus vectors |
| 02/09/2006 | WO2002097110A3 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060031968 Isolated plant deoxyhypusine synthase and nucleotides encoding same |
| 02/09/2006 | US20060031967 Compositions and methods for modulation of plant cell division |
| 02/09/2006 | US20060031965 In- seed expression of lysosomal enzymes |
| 02/09/2006 | US20060031963 Method for the production of ketocarotinoids in flower petals on plants |
| 02/09/2006 | US20060031962 Antifungal polypeptides |
| 02/09/2006 | US20060031961 Aldehyde reductase |
| 02/09/2006 | US20060031959 Nucleic acid fragments encoding proteins involved in stress response |
| 02/09/2006 | US20060031958 Soybean cultivar 943013 |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060031955 Novel culture systems for EX vivo development |
| 02/09/2006 | US20060031952 Methods for producing transgenic animals |
| 02/09/2006 | US20060031951 Improved modalities for the treatment of degenerative diseases of the retina |
| 02/09/2006 | US20060031945 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060031944 Embryonic stem cells capable of differentiating into desired cell lines |
| 02/09/2006 | US20060030527 Rage fusion proteins and methods of use |
| 02/09/2006 | US20060030524 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 02/09/2006 | US20060030487 Materials and methods for the regeneration of plants from cultured plant tissue |
| 02/09/2006 | US20060030045 Antisense modulation of c/ebp beta expression |
| 02/09/2006 | US20060030044 Method and composition for skin grafts |
| 02/09/2006 | US20060030043 Neural stem cell-collagen-bioreactor system to construct a functional embryonic brain-like tissue |
| 02/09/2006 | US20060030042 Maintenance of embryonic stem cells by the GSK-3 inhibitor 6-bromoindirubin-3'-oxime |
| 02/09/2006 | US20060030041 Multipotent adult stem cells and methods for isolation |
| 02/09/2006 | US20060030040 Human embryonic stem cells and culturing methods thereof |
| 02/09/2006 | US20060030039 culturing in medium comprising 1-methyl-3-isobutylxanthine to obtain cells having at least one characteristic of a neural cell; epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) are not added; cells obtained express neuron-specific enolase (NSE) and microtubule-associated protein 2 |
| 02/09/2006 | US20060030019 HDAC9 polypeptides and polynucleotides and uses thereof |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060030004 Solid phase synthesis |
| 02/09/2006 | US20060030003 Composition and method for introduction of RNA interference sequences into targeted cells and tissues |
| 02/09/2006 | US20060030002 Isoforms of the human Vitamin D receptor |
| 02/09/2006 | US20060029998 Codes with nucleic acids; antiinflammatory agents; immunomodulation |
| 02/09/2006 | US20060029997 nucleic acid sequence encoding an adhesive protein derived from a mollusk foot protein(MEFP-1); waterproof adhesives |
| 02/09/2006 | US20060029996 CDNA, or expression vector comprising the nucleotide sequence linked to an expression control sequence; biosynthesis of waterproof bioadhesive proteins, adhesins; high strength, durability |
| 02/09/2006 | US20060029989 Targeting cells having Mad2 mutation for treatment and/or prevention of disease |
| 02/09/2006 | US20060029984 PSP94 diagnostic reagents and assays |
| 02/09/2006 | US20060029983 Methods of screening compounds for GRK6 modulating activity |
| 02/09/2006 | US20060029966 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/09/2006 | US20060029945 Novel full length cDNA |
| 02/09/2006 | US20060029931 Small, interfering RNA (siRNA) molecules which inhibit expression of HALP (HIV-Associated Life Preserver) protein cloned into a plasmid or retroviral vector for introduction into host cells; screening HIV-modulating componds which prevent apoptosis resistance of infected cell; gene therapy |